Evaluation of ischemia-modified albumin in the diagnosis and the clinical severity of COVID-19 in children

Evaluation of ischemia-modified albumin in the diagnosis and the clinical severity of COVID-19 in children

Background. There is no specific biomarker used in the diagnosis of COVID-19 and predicting its clinical severity. This study aimed to investigate the utility of ischemia-modified albumin (IMA) in diagnosing and predicting clinical severity in children with COVID-19. Methods. Between O...

Full description

Saved in:
Bibliographic Details
Main Authors: Eda Karadağ Öncel, Dilek Yılmaz, Ahu Kara Aksay, Salim Neşelioğlu, Banu İşbilen Başok, İnanç Karakoyun, Tuba Kansu Altan, Selin Taşar, Gülnihan Üstündağ, Aslıhan Şahin, Yıldız Ekemen Keleş, Ayşegül Elvan Tüz, Özcan Erel
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2023-06-01
Series:The Turkish Journal of Pediatrics
Subjects:
COVID-19
child
clinical severity
diagnosis
ischemia-modified albumin
Online Access:https://turkjpediatr.org/article/view/49
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://turkjpediatr.org/article/view/49

Similar Items